Website Logo

Press

Keep up-to-date with relevant news, important announcements and key market insights.

READ MORE
FEATURED

Bionical Emas and Pharma Resources Announce Exclusive Global Clinical Trial Supply Partnership

About Bionical Emas

Bionical Emas is a global Early Access Programs (EAP) and Clinical Trial Supply (CTS) group bringing life-changing medicines to patients around the world. Our range of services and capabilities benefit many of the world’s leading pharma and biotech companies.

Learn more
READ MORE

Bionical Emas and Pharma Resources Announce Exclusive Global Clinical Trial Supply Partnership

READ MORE

Bionical Emas Earns 'B' Rating from the Carbon Disclosure Project, and Reinforces Commitment to Sustainability

READ MORE

Navigating data collection under Early Access Programs

READ MORE

Charity of the Year 2025 - RareQoL

READ MORE

Becarus Publishing: Innovative approaches to real-world data collection in UK Early Access Programs

READ MORE

Bionical Emas sells EMAS Pharma to Kester Capital following strategic review

READ MORE

Kester Capital backs experienced management team in acquiring EMAS Pharma

READ MORE

Bionical Emas is recognized as one of the UK’s Best Workplaces in BioPharma™!

READ MORE

Charity of the Year 2024 – The Dream Factory

READ MORE

The Guardian - Partnering with patients on their rare disease journey

READ MORE

Women in Healthcare - PharmaTimes May 2023

READ MORE

The Guardian - Inviting patients as equal partners in the drug development process

How else can we help?

Discover more about the services and capabilities Bionical Emas has to offer

READ MORE

Early Access Programs

READ MORE

Patient Advocacy and Patient Centricity

READ MORE

Clinical Trial Supply